Tenderwize
Back to tender search

Open-house discount agreement for nitisinone

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Jul 31, 2027 · 253 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Nitisinon, ATC A16AX04

54/100

Opportunity Score

Needs reviewHigh complexity
SuppliesOpen
Why this score?

Opportunity

54 / 100

Complexity

67 / 100

Risk factors

The open-house model is non-exclusive and the provided data contains no volume, value, or minimum-purchase commitment.

The AOK may replace the open-house contracts with exclusive rebate contracts, after which the open-house contracts end...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Jul 31, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Conclusion of non-exclusive pharmaceutical rebate contracts under sections 130a(8) and 130c(1) SGB V for Nitisinone, ATC A16AX04.
  • Contract period is linked to an earliest start of 1 October 2025 and ends at the latest 24 months after that date, namely 30 September 2027.
Show full summary

Open-house, non-exclusive pharmaceutical rebate contracts for Nitisinone (ATC A16AX04) with AOK Rheinland-Pfalz/Saarland. Eligible pharmaceutical companies may join under identical, non-negotiable conditions without a selection decision. Contracts may start on the first day of each month during the period and end no later than 30 September 2027. The notice states that this is not a public procurement under Directive 2014/24/EU. No contract value is provided. Procurement documents were not substantively analyzed; only the extracted TED XML notice was available.

Risks

The open-house model is non-exclusive and the provided data contains no volume, value, or minimum-purchase commitment.

The AOK may replace the open-house contracts with exclusive rebate contracts, after which the open-house contracts end...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only pharmaceutical companies may participate.
  • Medicines must be authorized and marketable in Germany.
  • Where the medicine is listed as marketable in the Lauer-Taxe, this serves as evidence.

Buyer

Lots (1)

LOT-0001

Nitisinone Pharmaceutical Rebate Contracts

Non-exclusive open-house rebate agreements for medicines containing Nitisinone, ATC A16AX04. Contracts are available to all interested pharmaceutical companies meeting the stated product and regulatory conditions; individual negotiations are not permitted. Medicines included on the BfArM list under section 35(5a) SGB V are excluded.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Sep 2025 - Sep 2027

Category

Pharmaceutical products

Deadline

Deadline Jul 31, 2027

Procurement Details

Publication date
05 Aug 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
515645-2025

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy